Cardiovascular Systems announced that the first patients in the United States were treated using the OrbusNeich Teleport Microcatheter, which recently received U.S. Food and Drug Administration 510 clearance. Microcatheters are used to provide support and safe guidewire exchange during complex cardiovascular procedures. Teleport is a new generation microcatheter designed for deliverability and support, with a unique and robust tip designed to enable access in the most challenging lesions.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.